SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,039 | -51.7% | 16,738 | +4.7% | 0.00% | – |
Q2 2023 | $20,788 | -19.8% | 15,991 | +8.6% | 0.00% | – |
Q1 2023 | $25,916 | -44.7% | 14,725 | -1.3% | 0.00% | – |
Q4 2022 | $46,865 | -35.8% | 14,925 | -0.0% | 0.00% | – |
Q3 2022 | $73,000 | +10.6% | 14,931 | -5.9% | 0.00% | – |
Q2 2022 | $66,000 | 0.0% | 15,868 | -0.2% | 0.00% | – |
Q1 2022 | $66,000 | -45.9% | 15,897 | -2.6% | 0.00% | – |
Q4 2021 | $122,000 | -20.3% | 16,318 | -4.0% | 0.00% | – |
Q3 2021 | $153,000 | -26.8% | 17,005 | -2.6% | 0.00% | – |
Q2 2021 | $209,000 | -7.1% | 17,457 | -2.6% | 0.00% | – |
Q1 2021 | $225,000 | -21.1% | 17,921 | -1.8% | 0.00% | – |
Q4 2020 | $285,000 | +77.0% | 18,245 | +7.1% | 0.00% | – |
Q3 2020 | $161,000 | -1.2% | 17,034 | -6.6% | 0.00% | – |
Q2 2020 | $163,000 | -31.5% | 18,239 | -51.2% | 0.00% | – |
Q1 2020 | $238,000 | +25.9% | 37,382 | +65.4% | 0.00% | – |
Q4 2019 | $189,000 | +6.8% | 22,604 | +15.8% | 0.00% | – |
Q3 2019 | $177,000 | – | 19,526 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |